Thermo Fisher Scientific Capabilities Update October 2026: Fill/Finish

Phase 2 is more than a clinical milestone — it's the point where development decisions begin to shape the commercial product. This presentation explores how sponsors can transition from an early clinical formulation to a scalable, patient-centric product by making informed choices on dosage form, container and delivery system, manufacturing strategy, and commercial readiness.

Learn how to balance technical, regulatory, and supply chain considerations while avoiding costly late-stage changes and preparing for successful technology transfer, scale-up, and commercialization.